Best Revascularization Strategy for Severe Carotid and Coronary Artery Disease

Courtesy of Dr. Carlos Fava.

Best Revascularization Strategy for Severe Carotid and Coronary Artery DiseaseCarotid artery disease is an important cause of stroke and is associated to coronary artery disease. When patients need myocardial revascularization surgery (Carotid Artery Bypass Graft) and cannot wait one month or more for carotid revascularization, the optimal management strategy is still controversial.

 

The aim of this study was to compare the evolution of three carotid revascularization strategies vs. CABG during the same hospitalization:

  • carotid endarterectomy + simultaneous CABG (CEA+CABG),
  • staged CEA + CABG (CEA+CABG2),
  • staged carotid stenting + CABG (CAS+CABG2).

 

Data were obtained from the Nationwide Inpatient Sample database 2004 to 2012. 

 

The study included 22,501 patients, 15,402 (68.4%) received CEA+CABG, 6,297 (28%) CEA+CABG2 and 802 (3.6%) CAS+CABG2. Patients undergoing CAS+CABG2 more often presented high blood pressure, diabetes, diabetes related complications, anemia, chronic obstructive pulmonary disease, obesity, kidney failure and prior coronary PCI.

 

Adjusted death risk was higher in the groups receiving CEA, whereas the risk of stroke was higher in those undergoing CAS. Combined death/stroke risk was similar with all three strategies.

 

For the octogenarian and women subgroup, the CAS+CABG2 strategy presented lower mortality and stroke. For symptomatic patients, CAS+CABG2 was associated with better evolution than the other two, presenting 3 times less mortality and 4 times less stroke.

 

Conclusion

In patients with carotid artery disease and concomitant coronary artery disease undergoing combined revascularization, the most used strategy was carotid endarterectomy + CABG in the same procedure, followed by staged endarterectomy + CABG and, lastly, staged carotid stenting + CABG. 

 

The strategy combining carotid stenting and CABG was associated with lower mortality risk but higher risk of stroke. Further research is required to find out the risk benefit/ratio of the different revascularization strategies in high risk patients.

 

Editorial Comment

This analysis shows that carotid endarterectomy is the most used strategy. Carotid stenting presented lower mortality but globally had a higher rate of stroke, even though performed in high risk patients, which we should take into account.

 

When higher risk populations were analyzed, carotid stenting showed better results than carotid endarterectomy in patients with concomitant coronary artery disease.

 

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

 

Original Title: Comparison of trend and In-Hospital Outcomes of Concurrent carotid Artery Revascularization and Coronary Artery Bypass Graft Surgery. The United States Experience 2004 to 2012.

Reference: Feldman DN et al. J Am Coll Cardiol Interv 2017;10:286-98.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...